Immunohistochemical Study of NR2C2, BTG2, TBX19, and CDK2 Expression in 31 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas

Figure 2

BTG2 and CDK2 expressed in each group. (Aa): BTG2 highly expressed in primary recurrent group; (Ab): BTG2 lowly expressed in nonrecurrent group. (Ba): CDK2 highly expressed in primary recurrent group; (Bb): CDK2 lowly expressed in nonrecurrent group.